Innovating Works

GLYCANOSTICS SRO

Desconocido
ProSCAN: Prostate cancer diagnostics using a non-invasive test based on innovative glycan-based scanning GLYCANOSTICS SRO tramitó un HORIZON EUROPE HORIZON-EIC-2021-ACCELERATORCHALLENGES-01 Prostate cancer (PCa) is the 2nd most frequent cancer in men with 1.4M new annual cases and nearly 0.4M deaths worldwide in 2020. PCa incide...
2022-03-30 - 2024-02-29 | Financiado
GlyCan: Innovative Glycan based analysis for Cancer diagnostics GLYCANOSTICS SRO tramitó un H2020 H2020-EIC-SMEInst-2018-2020 Worldwide, there are 1.6M new prostate cancer (PCa) cases with 366k deaths annually. Novel PCa biomarkers are needed since the best current...
2019-01-28 - 2019-08-31 | Financiado
Andrea: A Novel Detection protocols for REliable prostate cancer Assays GLYCANOSTICS SRO participó en un H2020 ERC-2018-PoC The technology validation was successfully completed indicating a great commercial potential, and the innovative and inventive aspects of th...
2018-11-28 - 2020-08-31 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.